To study the role of CMV in the suppression of hemopoiesis that frequently accompanies infection, we investigated the effect of CMV on the growth of isolated committed myeloid …

2024年5月16日 · It is widely used for the treatment of CMV infections among patients with impaired cell-mediated immunity, particularly persons with poorly controlled and advanced …

In allogeneic hematopoietic stem cell transplant recipients with bone marrow (BM) suppression, cytomegalovirus (CMV) pp65 antigenemia and DNA were detectable in peripheral blood …

To investigate the possible role of CMV in the suppression of hematopoiesis, we have examined the effect of CMV on the growth of isolated myeloid progenitors and on the production of …

Currently, valganciclovir and ganciclovir are the preferred and first-line agents for treatment of CMV viremia and infection. However, bone marrow suppression is a major limitation of these …

2014年6月1日 · In allogeneic hematopoietic stem cell transplant recipients with bone marrow (BM) suppression, cytomegalovirus (CMV) pp65 antigenemia and DNA were detectable in …

2019年11月13日 · Human cytomegalovirus (HCMV) infection could lead to life-threatening complications in immunocompromised and immunosuppressed populations, especially after …

1990年2月15日 · To study the role of CMV in the suppression of hemopoiesis that frequently accompanies infection, we investigated the effect of CMV on the growth of isolated committed …

Cytomegalovirus (CMV) infection or reactivation is a frequent cause of morbidity and mortality in recipients of allogeneic bone marrow transplant (BMT). Some patients with CMV reactivation …

2019年12月19日 · For the first time, scientists have discovered the molecular mechanism behind how a common virus can wreak havoc on bone marrow and organ transplant patients, …